Baidyanath Chopchiniyadi Churna
Price range: ₹13.95 through ₹39.95
Product Description
Baidyanath Chopchiniyadi Churna
Therapatic Uses of Baidyanath Chopchiniyadi Churna :
- Used in Syphilis, Gout, Rheumatism, Seminal Weakness, Epilepsy, Malignant Ulcers and Nervous Disease.
Composition (Each 10gm Baidyanath Chopchiniyadi Churna contains) :
- Shatavar, Gokhru, Bijband, Banslochan, Kababchini, Chopchini, Kaunch Beej, Safed Musli, Trikatu, Salam Mishri, Bidarikhand, Ashwagandha, Nishoth
Dosage of Baidyanath Chopchiniyadi Churna :
1 to 2 teaspoonful with Baidyanath Manjisthadi Kadha or milk.
Additional Information
| Quantity | 120g (2 x 60g), 240g (4 x 60g), 480g (8 x 60g) |
|---|
Be the first to review “Baidyanath Chopchiniyadi Churna”
Related Products
Baidyanath Madiphal Rasayanam
₹14.95
Select options
This product has multiple variants. The options may be chosen on the product page
Baidyanath Abhayarishta
Price range: ₹22.45 through ₹36.95
Select options
This product has multiple variants. The options may be chosen on the product page
Baidyanath Mall Tail
Original price was: ₹764.00.₹687.00Current price is: ₹687.00.
Baidyanath Draksharishta
Price range: ₹22.95 through ₹55.45
Select options
This product has multiple variants. The options may be chosen on the product page
Baidyanath Vita-Ex Gold Capsules
Original price was: ₹785.00.₹750.00Current price is: ₹750.00.
Baidyanath Balarishta
Price range: ₹21.45 through ₹37.45
Select options
This product has multiple variants. The options may be chosen on the product page
Baidyanath Maha Manjishthadyarishta
Price range: ₹22.45 through ₹55.95
Select options
This product has multiple variants. The options may be chosen on the product page
Baidyanath Dashmoolarista
Price range: ₹22.95 through ₹55.45
Select options
This product has multiple variants. The options may be chosen on the product page
Baidyanath Jeerakarishtam
Price range: ₹19.95 through ₹55.95
Select options
This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.